Last Updated: May 14, 2026

TERBINAFINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Terbinafine patents expire, and when can generic versions of Terbinafine launch?

Terbinafine is a drug marketed by Sun Pharma Canada, Aurobindo Pharma, Breckenridge Pharm, Chartwell, Cipla, Emed Medcl, Gedeon Richter Usa, Glenmark Pharms Ltd, Heritage Pharma Avet, Invagen Pharms, Mylan, Natco Pharma, Orbion Pharms, Roxane, Senores Pharms, and Wockhardt. and is included in sixteen NDAs.

The generic ingredient in TERBINAFINE is terbinafine hydrochloride. There are twenty-seven drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the terbinafine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Terbinafine

A generic version of TERBINAFINE was approved as terbinafine hydrochloride by SUN PHARMA CANADA on July 2nd, 2007.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for TERBINAFINE?
  • What are the global sales for TERBINAFINE?
  • What is Average Wholesale Price for TERBINAFINE?
Recent Clinical Trials for TERBINAFINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Swiss Cancer InstitutePHASE2
Cairo UniversityNA
Assiut UniversityNA

See all TERBINAFINE clinical trials

US Patents and Regulatory Information for TERBINAFINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Canada TERBINAFINE HYDROCHLORIDE terbinafine hydrochloride CREAM;TOPICAL 077511-001 Jul 2, 2007 OTC No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Gedeon Richter Usa TERBINAFINE HYDROCHLORIDE terbinafine hydrochloride TABLET;ORAL 077065-001 Jul 2, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell TERBINAFINE HYDROCHLORIDE terbinafine hydrochloride TABLET;ORAL 078199-001 Jul 2, 2007 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Natco Pharma TERBINAFINE HYDROCHLORIDE terbinafine hydrochloride TABLET;ORAL 077195-001 Jul 2, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Glenmark Pharms Ltd TERBINAFINE HYDROCHLORIDE terbinafine hydrochloride TABLET;ORAL 078157-001 Jul 2, 2007 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.